Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-15-001245
Filing Date
2015-11-16
Accepted
2015-11-16 14:27:59
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cnab_10q.htm 10-Q 541739
2 CERTIFICATION cnab_ex31z1.htm EX-31 7263
3 CERTIFICATION cnab_ex32z1.htm EX-32 2860
  Complete submission text file 0001553350-15-001245.txt   5340476

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE cnab-20150930.xml EX-101.INS 890421
5 XBRL SCHEMA FILE cnab-20150930.xsd EX-101.SCH 61824
6 XBRL CALCULATION FILE cnab-20150930_cal.xml EX-101.CAL 62249
7 XBRL DEFINITION FILE cnab-20150930_def.xml EX-101.DEF 228839
8 XBRL LABEL FILE cnab-20150930_lab.xml EX-101.LAB 961728
9 XBRL PRESENTATION FILE cnab-20150930_pre.xml EX-101.PRE 464923
Mailing Address 1600 BROADWAY SUITE 1600 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 1600 DENVER CO 80202 (407) 432-2547
United Cannabis Corp (Filer) CIK: 0001436161 (see all company filings)

EIN.: 261391338 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54582 | Film No.: 151233502
SIC: 2834 Pharmaceutical Preparations